Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor

Shimpei Kawamoto(Tohoku Institute of Technology), E. Hara(The University of Osaka), Daisuke Torigoe(Kumamoto University), Naoki Mochizuki(National Cerebral and Cardiovascular Center), Koyu Ito(The University of Osaka), Mikako Maruya(RIKEN Center for Integrative Medical Sciences), Masataka Sugimoto(National Center for Geriatrics and Gerontology), A Takahashi(Japanese Foundation For Cancer Research), Takumi Mikawa(Kyoto University), Sho Sugawara, Haruki Horiguchi(Kumamoto University), Masahiro Wakita(The University of Osaka), Yumiko Okumura(The University of Osaka), B. Jung(The University of Osaka), Nozomi Hori(The University of Osaka), Jeong Hoon Park(The University of Osaka), Hideka Miyagawa(The University of Osaka), Xiangyu Zhou(Japanese Foundation For Cancer Research), Ken Uemura(The University of Osaka), Hiroshi Kondoh(Kyoto University Hospital), Y. Oike(Kumamoto University)
EMBO Reports
April 3, 2026
Cited by 2


Related Papers